SEC Form 4 · accession 0001127602-18-034829
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley C Erck
Director
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 28, 2018 | M | 8,333 | $1.49 | A | 48,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option | $1.49 | Nov 28, 2018 | M | 8,333 | D | Jan 22, 2009 | Dec 22, 2018 | Common Stock | 8,333 | 0 | D |